Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane for subjective tinnitus (randomized double-blind placebo-controlled Phase 3)
2007-007835-16Phase 3Completed
- Sponsor
- Merz
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in tinnitus comparing Neramexane with Placebo (2 arms). Primary endpoint: Change in TBF-12 score from baseline to end of treatment. Started Jun 2008; status: completed.
02
Drugs
neramexane
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2007-007835-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007835-16.